128 related articles for article (PubMed ID: 6234897)
41. Proportional and functional studies of the infiltrating lymphocytes in the parotid gland of Sjögren's syndrome associated with rheumatoid arthritis.
Ichikawa Y; Gonzalez EB; Daniels JC
Clin Exp Rheumatol; 1984; 2(1):23-30. PubMed ID: 6335860
[TBL] [Abstract][Full Text] [Related]
42. [Lymphocytotoxic antibodies in rheumatoid arthritis].
Mine M
Ryumachi; 1983 Apr; 23(2):85-92. PubMed ID: 6604341
[No Abstract] [Full Text] [Related]
43. Rheumatoid vasculitis in a patient with seronegative rheumatoid arthritis.
Ikeda E; Uchigasaki S; Endo M; Shibata M; Suzuki H
Eur J Dermatol; 1998 Jun; 8(4):268-70. PubMed ID: 9649673
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the clinical characteristics of vasculitis occurring during anti-tumor necrosis factor treatment or not in rheumatoid arthritis patients. A systematic review of 2707 patients, 18 vasculitis.
Guignard S; Gossec L; Bandinelli F; Dougados M
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S23-9. PubMed ID: 18799049
[TBL] [Abstract][Full Text] [Related]
45. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass.
Cambridge G; Williams M; Leaker B; Corbett M; Smith CR
Ann Rheum Dis; 1994 Jan; 53(1):24-9. PubMed ID: 8311550
[TBL] [Abstract][Full Text] [Related]
46. Selective loss of suppressor T cells in rheumatoid arthritis patients: analysis of peripheral blood lymphocytes by 2-dimensional flow cytometry.
Goto M; Miyamoto T; Nishioka K; Okumura K
J Rheumatol; 1986 Oct; 13(5):853-7. PubMed ID: 2950232
[TBL] [Abstract][Full Text] [Related]
47. Anti-lactoferrin antibodies in patients with rheumatoid arthritis with vasculitis.
Coremans IE; Hagen EC; van der Woude FJ; Daha MR; van der Voort EA; Kleyburg-van der Keur C; Breedveld FC
Adv Exp Med Biol; 1993; 336():357-62. PubMed ID: 8296635
[TBL] [Abstract][Full Text] [Related]
48. Serum from patients with autoimmune diseases induces in vitro production of disease-associated antibodies by peripheral blood mononuclear cells from normal subjects.
Kanazawa H; Eguchi K; Mine M; Ikari N; Kurata A; Fukuda T; Matsunaga M; Nagataki S
J Clin Endocrinol Metab; 1986 Sep; 63(3):683-8. PubMed ID: 2942556
[TBL] [Abstract][Full Text] [Related]
49. Studies on antilymphocyte antibodies in patients with rheumatoid arthritis and systemic lupus erythematosus.
Winchester RJ; Winfield JB; Fu SM; Wernet P; Kunkel HG
Rheumatology; 1975; 6():209-14. PubMed ID: 1081726
[TBL] [Abstract][Full Text] [Related]
50. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.
Tamura N; Kobayashi S; Kato K; Bando H; Haruta K; Oyanagi M; Kuriyama M; Kipps TJ; Hashimoto H
J Rheumatol; 2001 Dec; 28(12):2583-90. PubMed ID: 11764201
[TBL] [Abstract][Full Text] [Related]
51. Antilymphocyte antibodies in rheumatoid arthritis: increased reactivity against activated lymphocytes.
Searles RP; Messner RP; Hermanson SM
Clin Immunol Immunopathol; 1981 Aug; 20(2):246-54. PubMed ID: 7261482
[No Abstract] [Full Text] [Related]
52. Immobilized IgG-aggregate-induced cytolytic activity of lymphocytes from patients with rheumatoid arthritis.
Fuson EW; Whittaker RL; Beard MR
J Clin Lab Immunol; 1984 Dec; 15(4):181-6. PubMed ID: 6241257
[TBL] [Abstract][Full Text] [Related]
53. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
[TBL] [Abstract][Full Text] [Related]
54. Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis.
van Gaalen FA; Toes RE; Ditzel HJ; Schaller M; Breedveld FC; Verweij CL; Huizinga TW
Arthritis Rheum; 2004 Feb; 50(2):395-9. PubMed ID: 14872481
[TBL] [Abstract][Full Text] [Related]
55. Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis.
Rapoport RJ; Kozin F; Mackel SE; Jordon RE
Am J Med; 1980 Mar; 68(3):325-31. PubMed ID: 6987869
[TBL] [Abstract][Full Text] [Related]
56. T lymphocyte subpopulations defined by monoclonal antibodies in synovial fluid of patients with rheumatic disease.
Nilsson E; Biberfeld G
J Clin Lab Immunol; 1982 Nov; 9(2):93-7. PubMed ID: 6984082
[TBL] [Abstract][Full Text] [Related]
57. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
[TBL] [Abstract][Full Text] [Related]
58. Immunoregulation of immunoglobulin production in normal infants and children.
Nouri-Aria KT; Lobo-Yeo A; Vergani D; Mieli-Vergani G; Mowat AP; Eddleston AL
Clin Exp Immunol; 1985 Mar; 59(3):679-86. PubMed ID: 3157518
[TBL] [Abstract][Full Text] [Related]
59. The isolation and characterization of the human suppressor inducer T cell subset.
Morimoto C; Letvin NL; Distaso JA; Aldrich WR; Schlossman SF
J Immunol; 1985 Mar; 134(3):1508-15. PubMed ID: 3155770
[TBL] [Abstract][Full Text] [Related]
60. Rheumatoid arthritis and sterile corneal ulceration. Analysis of tissue immune effector cells and ocular epithelial antigens using monoclonal antibodies.
Michels ML; Cobo LM; Caldwell DS; Rice JR; Haynes BF
Arthritis Rheum; 1984 Jun; 27(6):606-14. PubMed ID: 6233985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
